SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Teslas scheduled Cybercab/robotaxi launch, alongside reported expansion of unsupervised Austin testing and fleet additions, is driving attention. Traders are divided between bullish expectations that autonomy will accelerate Teslas AI and mobility opportunity and concerns that the event may trigger a buy the rumor, sell the news reversal amid valuation and execution risks.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Recent strong earnings and BioCrysts profitable Orladeyo franchise are being weighed against unconfirmed buyout speculation and the companys shift toward acquiring external rare-disease assets. Traders remain divided, with bullish investors focused on pediatric Orladeyo growth and future navenibart data, while others cite competition, pipeline uncertainty, low volume, and stagnant price action.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Attention centers on SELLASs event-driven REGAL Phase 3 trial, which remains officially at 78 of 80 events and is nearing the milestone that triggers final efficacy analysis for GPS in AML. Traders are divided between bullish interpretations of the prolonged event accrual and industry comments calling GPS a potential game changer, and bearish concerns about trial design, control-arm survival, and the binary readout risk.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apples CEO transition from Tim Cook to John Ternus and the upcoming iPhone launchpotentially featuring a foldable model and upgraded Siriare driving attention, with traders positioning for a pre-event rally. The community is divided between bullish product-cycle expectations and concerns about valuation, memory costs, margins, and a possible sell-the-news reaction.

Zoracles

A sharp price and volume surge has pushed ZORA into focus, with traders citing its small market cap, rising activity and potentially crowded futures shorts as fuel for a short squeeze. Others caution that the move may be a speculative pump-and-dump, leaving the fundamental catalyst unconfirmed.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Escalating U.S.-Iran hostilities and reported strikes near the Strait of Hormuz are driving attention, with traders linking the conflict to oil-market volatility, higher inflation, and broader market risk. The community is divided between bearish views that the war and rising fuel costs will hurt markets and supportive views that Trumps actions will strengthen regional leverage, alongside discussion of a Venezuelan oil deal as a potential offset.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Visas monitoring of Hims & Hers over elevated payment disputes tied to weight-loss subscriptions, alongside ongoing FTC scrutiny, is driving attention and selling pressure. Traders debate whether the issues are temporary growing pains and an overblown reaction or evidence of deeper subscription and compliance risks, while bulls continue to cite the companys telehealth, GLP-1, peptide and AI growth opportunities.

GE Vernova, Inc. engages in the electric power industry. It operates through the following segments: Power, Wind, and Electrification. The Power segment offers design, manufacture, and servicing gas, nuclear, hydro, and steam technologies, providing a critical foundation of dispatchable, flexible, stable, and reliable power. The Wind segment manages wind generation technologies, including onshore and offshore wind turbines and blades. The Electrification segment refers to the grid solutions, power conversion, electrification software, and solar and storage solutions technologies required for the transmission, distribution, conversion, storage, and orchestration of electricity from point of generation to point of consumption. The company was founded November 9, 2021 and is headquartered in Cambridge, MA.

GE Vernova Inc.

A mixed second-quarter earnings reportan earnings miss despite a revenue beat and raised full-year outlookhas driven a sharp selloff and intense debate. Traders are split between viewing the move as a valuation or profit-taking reaction and maintaining the long-term AI power and grid thesis on strong orders, turbine demand, and backlog.

iShares Trust - iShares Expanded Tech-Software Sector ETF

iShares Expanded Tech-Software Sector ETF

A broad software-sector rebound and rotation from semiconductors and AI infrastructure is driving attention, as traders reassess the SaaSpocalypse thesis after strong software earnings and evidence that AI may enhance, rather than replace, established SaaS workflows. The community remains divided over whether the move represents durable renewed leadership or a short-lived rotation vulnerable to rising yields, stretched valuations, and continued AI-disruption concerns.

Aduro Clean Technologies, Inc. engages in the manufacture of oils and specialty chemicals using waste plastics. It focuses on hydrochemolytic technology to transform post-consumer polymer waste into a resource for the circular economy. It also develops a novel chemical conversion process to transform waste plastics and low grade renewable oils into renewable fuels and specialty chemicals. The company was founded on January 10, 2018 by Ofer Vicus and William Marcus Trygstad and is headquartered in Sarnia, Canada.

Aduro Clean Technologies Inc

Attention is focused on Aduros progress toward commercializing its Hydrochemolytic Technology, including the ECOCE Mexico plastics collaboration moving into HCT testing, AstroTurf recycling work, and engineering support for its first-of-a-kind facility. Bulls view these milestones and rising volume as validation of a broad clean-tech opportunity, while skeptics continue to question the processs commercial economics and lengthy path to revenue.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of products that address significant unmet needs in Central Nervous System (CNS) disorders and other rare disorders. The company was founded by Raj Mehra in 1987 and is headquartered in New York, NY.

Seelos Therapeutics Inc

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info